Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Co-logne, Joseph Stelzmann Strasse 26, 50931 Cologne, Germany.
Curr Genomics. 2014 Feb;15(1):38-51. doi: 10.2174/138920291501140306113344.
Damaged and misfolded proteins accumulate during the aging process, impairing cell function and tissue homeostasis. These perturbations to protein homeostasis (proteostasis) are hallmarks of age-related neurodegenerative disorders such as Alzheimer's, Parkinson's or Huntington's disease. Damaged proteins are degraded by cellular clearance mechanisms such as the proteasome, a key component of the proteostasis network. Proteasome activity declines during aging, and proteasomal dysfunction is associated with late-onset disorders. Modulation of proteasome activity extends lifespan and protects organisms from symptoms associated with proteostasis disorders. Here we review the links between proteasome activity, aging and neurodegeneration. Additionally, strategies to modulate proteasome activity and delay the onset of diseases associated to proteasomal dysfunction are discussed herein.
在衰老过程中,受损和错误折叠的蛋白质会积累,从而损害细胞功能和组织内稳态。这些蛋白质平衡(proteostasis)的紊乱是与年龄相关的神经退行性疾病(如阿尔茨海默病、帕金森病或亨廷顿病)的标志。受损的蛋白质通过细胞清除机制(如蛋白酶体)降解,蛋白酶体是蛋白质平衡网络的关键组成部分。蛋白酶体的活性随着衰老而下降,蛋白酶体功能障碍与迟发性疾病有关。调节蛋白酶体的活性可以延长寿命,并保护生物体免受与蛋白质平衡紊乱相关的症状的影响。在这里,我们回顾了蛋白酶体活性、衰老和神经退行性变之间的联系。此外,本文还讨论了调节蛋白酶体活性和延缓与蛋白酶体功能障碍相关疾病发作的策略。